ParenteralTopicalTherapeutic flag Cosmetic cross-reference

Riboflavin 5'-Phosphate

CAS 130-40-5

Riboflavin 5'-Phosphate (CAS 130-40-5) is a Phase 4 pharmaceutical compound with 3 bioactivity targets and 446 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
446
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Riboflavin 5'-Phosphate
CAS Number
130-40-5
UNII
20RD1DZH99
InChIKey
FVTCRASFADXXNN-SCRDCRAPSA-N
ChEMBL ID
CHEMBL1201794
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
RIBOFLAVIN 5'-PHOSPHATE SODIUM
natural productparenteraltherapeutic flagtopical
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1201794 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 26544.824137931035 nM 58 -
- Kd 22833.333333333332 nM 3 -
- IC50 55000 nM 2 -
SOURCE DrugCentral 17 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Corneal opacity 40 225.113 10011035
Corneal infiltrates 21 135.737 10011022
Corneal epithelium defect 20 110.685 10011010
Corneal scar 15 89.868 10011044
Corneal thinning 14 85.525 10054760
Incorrect product formulation administered 10 59.024 10074946
Corneal oedema 14 54.153 10011033
Eye pain 29 53.65 10015958
Therapy cessation 25 44.929 10065154
Ulcerative keratitis 13 43.839 10064996
Keratitis 11 34.032 10023332
Keratoplasty 4 33.369 10066900
No adverse event 24 30.88 10067482
Off label use 5 27.354 10053762
Corneal striae 3 20.367 10052118
Corneal perforation 5 19.9 10011039
Infective keratitis 3 18.447 10076672

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 3 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
RIBOFLAVIN 5'-PHOSPHATE SODIUM 1925820 SU MTHSPL
RIBOFLAVIN 5'-PHOSPHATE 1925821 SU MTHSPL
riboflavin 5'-phosphate 1925821 IN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Riboflavin 5'-Phosphate used for in pharmaceutical contexts?

Riboflavin 5'-Phosphate (CAS 130-40-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Riboflavin 5'-Phosphate?

Riboflavin 5'-Phosphate has 446 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Corneal opacity, Corneal infiltrates, Corneal epithelium defect, Corneal scar, Corneal thinning. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Riboflavin 5'-Phosphate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Riboflavin Phosphate with EU status "permitted".

What clinical phase is Riboflavin 5'-Phosphate in?

Riboflavin 5'-Phosphate is rendered with ChEMBL max phase 4 (approved).